Cipla
Break Gilead’s patent since US has bought all stock of Remdesivir
Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far
US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug
Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.
- Film on Gaza solidarity encampments is launched amid Trump’s crackdown on student activism
- European leaders press ahead with armament plans amid Ukraine peace negotiations
- Syrian interim government continues to attack Lebanon after reaching ceasefire deal
- In major blow against free speech, environmental group ordered to pay USD 667 million to pipeline corporation
- Panamanian workers mobilize against Social Security privatization
